Filter
69
Text search:
astra
Featured
Recommendations
10
New Publications
2
Language
Document type
Fact sheets
17
Studies & Reports
14
No document type
13
Guidelines
10
Resource Platforms
6
Strategic & Response Plan
5
Situation Updates
3
Manuals
1
Countries / Regions
Germany
5
Ukraine
4
East and Southern Africa
4
India
3
West and Central Africa
3
Western and Central Europe
3
Global
3
South Sudan
2
Kenya
2
Brazil
2
Congo, Democratic Republic of
1
Syria
1
South Africa
1
Argentina
1
Austria
1
Switzerland
1
Colombia
1
El Salvador
1
Madagascar
1
Chile
1
South–East Asia Region
1
Paraguay
1
Africa
1
Eastern Europe
1
Russia
1
South Korea
1
Authors & Publishers
Publication Years
Category
Countries
27
Public Health
3
Clinical Guidelines
3
Annual Report MEDBOX
1
Key Resources
1
Toolboxes
COVID-19
39
NCDs
8
Mental Health
7
Conflict
4
Disability
1
Rapid Response
1
HIV
1
TB
1
Caregiver
1
Planetary Health
1
NTDs
1
Health Financing Toolbox
1
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence s
...
временное руководство. Первый выпуск: 10 февраля 2021 г. Обновлено: 21 апреля 2021 г. Последнее обновление 30 июля 2021г.
Comment The Lancet Volume 397, ISSUE 10269, P72-74, January 09, 2021
Published:December 08, 2020DOI:https://doi.org/10.1016/S0140-6736(20)32623-4
On the 9 February 2021, Africa CDC convened a special session of the Africa Task Force for COVID-19 to review existing data and evidence and recommend
On the 9 February 2021, Africa CDC convened a special session of the Africa Task Force for COVID-19 to review existing data and evidence and recommend
An overview of COVID-19 Vaccine AstraZeneca and why it is authorised in the EU. Available in 22 languages
18 Febr. 2021
New England Journal of Medicine
April 9, 2021
DOI: 10.1056/NEJMoa2104840
10 May 2021. Manufactureres:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
The ChAdOx1-S/nCoV-19 [recombinant] vaccine is a replication-deficient adenoviral vecto
...
orientations provisoires, première publication: 10 février 2021, mise à jour : 21 avril 2021, dernière mise à jour : 30 juillet 2021
7 April 2021
Based on current information, a causal relationship between the vaccine and the occurrence of blood clots with low platelets is considered plausible but is not confirmed.
Available in Englisch, French and Russian
REG 174 INFORMATION FOR UK HEALTHCARE PROFESSIONALS
Este documento de referência foi preparado pelo Grupo de Trabalho sobre Vacinas contra COVID-19 do Grupo Consultivo Estratégico de Especialistas em Imunização (SAGE) para orientar as discussões do SAGE em sua reunião extraordinária de 8 de fevereiro de 2021, que resultou na publicação do do
...
